Geron Corp. will shed 43 jobs, kill its brain cancer drug program and focus development on another cancer drug, called imetelstat, the company said Monday.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/12/geron-gern-brain-cancer-stem-cells.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/12/geron-gern-brain-cancer-stem-cells.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29
No comments:
Post a Comment